KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Interest & Investment Income (2016 - 2018)

Historic Interest & Investment Income for Emergent BioSolutions (EBS) over the last 10 years, with Q3 2018 value amounting to $701000.0.

  • Emergent BioSolutions' Interest & Investment Income rose 1004.71% to $701000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.4 million, marking a year-over-year decrease of 2619.55%. This contributed to the annual value of $1.8 million for FY2017, which is 6647.67% up from last year.
  • Emergent BioSolutions' Interest & Investment Income amounted to $701000.0 in Q3 2018, which was up 1004.71% from $306000.0 recorded in Q2 2018.
  • Emergent BioSolutions' Interest & Investment Income's 5-year high stood at $701000.0 during Q3 2018, with a 5-year trough of $31000.0 in Q2 2014.
  • Moreover, its 5-year median value for Interest & Investment Income was $219000.0 (2016), whereas its average is $259263.2.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 95555.56% in 2014, then tumbled by 4751.29% in 2018.
  • Emergent BioSolutions' Interest & Investment Income (Quarter) stood at $190000.0 in 2014, then tumbled by 40.53% to $113000.0 in 2015, then surged by 155.75% to $289000.0 in 2016, then tumbled by 44.64% to $160000.0 in 2017, then soared by 338.12% to $701000.0 in 2018.
  • Its last three reported values are $701000.0 in Q3 2018, $306000.0 for Q2 2018, and $222000.0 during Q1 2018.